Ecraid's annual report for 2023 now available
2023 was Ecraid’s first fully operational year, during which the foundation made significant progress. The annual report, now available for download, offers a comprehensive overview of this pivotal year for our foundation.
The three-person Management Board emphasizes in the annual report the rapid establishment of the new organisation while maintaining a focus on its robustness. A lot was invested in the collaboration with a diverse group of stakeholders. Ecraid’s infrastructure has also strengthened. For instance, june 2023 saw the kick-off of the Ecraid Clinical Liaisons (ECLs) Council, enhancing Ecraid’s presence at a national and regional level.
The year concluded with positive results and earnings surpassing the annual target. Most importantly, we made substantial advances in research. Our perpetual observational studies made major progress with patient inclusion in 2023. The annual report also provides an overview of the studies Ecraid participated in.
Besides the information on Ecraid’s many achievements in 2023, the annual report features interviews with people who have been involved with our foundation in various ways, as well as Ecraid’s newest asset, the P3-network.